Maintenance agreement for item #DCS-sctx - directcare standard service for stellant SX contrast injector
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201300115P
- Awardee
-
Medrad, Inc. UEI HC7UTN8VR227
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,890
Award facts
- Contract value 100% obligated
- $1,890.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Warrendale, PA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,890 | |
| Original award | $3,780 |
About this award
The National Cancer Institute awarded a purchase order to Medrad, Inc. for a maintenance agreement covering DirectCare Standard Service for a Stellant SX contrast injector, valued at $1,890.00, with an award date of March 1, 2013. Performance occurs in Warrendale, Pennsylvania. The order is firm fixed price with an ultimate completion date of February 28, 2014.
Quick answers
Who was awarded contract HHSN261201300115P?
HHSN261201300115P was awarded to Medrad, Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2013.
How much is contract HHSN261201300115P worth?
The government has obligated $1,890 on HHSN261201300115P.
Was contract HHSN261201300115P competed?
The extent of competition for HHSN261201300115P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award